erevnon Posted - 2 days ago

Barrington Research maintains PaySign $PAYS at Outperform and raises the price target from $5.5 to https://marketsblock.com/stock-upgrades-and-downgrades/

ZDVIC Posted - 2 days ago

$NSAV $RKLB $PAYS $ENVX

khmerxbxboi Posted - 2 days ago

$PAYS = wake me up when this baby hits $6+

khmerxbxboi Posted - 3 days ago

$PAYS = $6+

tin_bird1 Posted - 3 days ago

$PAYS be nimble Jack

Jpike55 Posted - 4 days ago

$PAYS In 5 months it went from 1.20 to 4.70 so if it profit takes a few cents so be it. Not many stocks moved that high that fast but the good news is price targets by analysts are even higher now. This company is on the radar of big pharma and others. Quality small company.

Stockpooper30 Posted - 4 days ago

$PAYS WHY THE FUCK IS THIS DOWN !!

erevnon Posted - 4 days ago

Maxim Group maintains PaySign $PAYS at Buy and raises the price target from $5.5 to https://marketsblock.com/stock-upgrades-and-downgrades/

Jpike55 Posted - 5 days ago

$PAYS Solid growth with very bright future. ...and this was our weakest yearly quarter.

aghoghari Posted - 5 days ago

$PAYS This gonna tank 5 percent in coming week

DonCorleone77 Posted - 5 days ago

$PAYS Paysign backs FY24 revenue view $54.5M-$56.7M, consensus $55.72M "Our first quarter financial results were solid across all metrics. The strong growth in our pharma patient affordability business continued into the first quarter, which helped offset the seasonal effects we typically see in our plasma business where donations are lower from the fourth quarter as individuals receive their tax refund checks from the Federal government in the first quarter. Gross profit margins continued to improve with the mix shift to a greater percentage of pharma revenue, which increased to 18% of total revenue for the quarter. Adjusted EBITDA of $1.7 million increased 135% from the previous year, as we benefited from strong revenue growth and cost control despite ongoing investments in technology and people. Our adjusted EBITDA margin improved to 12.8% during the quarter from 7.1% for the same period last year. Our unrestricted cash balances remain strong and we remain debt free. Based on our first quarter financial results and financial expectations for the remainder of the year, we are confirming the guidance we gave in March, for total revenues to be in the range of $54.5 million to $56.7 million and adjusted EBITDA to be in the range of $8.0 million to $9.0 million," said Jeff Baker, Paysign CFO.

DonCorleone77 Posted - 5 days ago

$PAYS Paysign sees Q2 revenue up 27.5%, consensus $13.2M "For the second quarter of 2024, we expect total revenue to increase by approximately 27.5% over the second quarter of 2023 with pharma revenue accounting for approximately 18.0% of the total. We expect adjusted EBITDA to increase 65.0% to 70.0% from the second quarter of 2023 with an adjusted EBITDA margin in the range of 13.5% to 14.0%," Baker concluded.

DonCorleone77 Posted - 5 days ago

$PAYS Paysign reports Q1 EPS 1c, consensus 0c Reports Q1 revenue $13.19M, consensus $12.39M. "We are delighted to announce our financial results for the first quarter of 2024. During this period, our revenue saw a 30% increase compared to the first quarter of the previous year, while our adjusted EBITDA grew by 135%, demonstrating strong growth in both top and bottom lines. Our patient affordability business has been expanding rapidly, marking a significant 305% rise in revenue over the first quarter of 2023, solidifying its role as a major driver of growth for the company," stated Mark Newcomer, President & CEO of Paysign. "As we look ahead to the rest of the year, we anticipate continued growth across all our business units. We are particularly optimistic about the future of our patient affordability business, given its robust pipeline and our swift addition of new programs. We expect our plasma compensation business to maintain stable, moderate growth as the industry adjusts to recent rapid expansions. Our commitment remains firm on achieving sustainable growth in both revenue and earnings, exploring profitable market opportunities, and delivering long-term value to our shareholders."

Stock_Titan Posted - 5 days ago

$PAYS Paysign, Inc. Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/PAYS/paysign-inc-reports-first-quarter-2024-financial-61pqql28700w.html

Stockpooper30 Posted - 5 days ago

$PAYS WHAT YOUR GUYS THOUGHT HERE !!! HOW DO YOU THINK EARNINGS ARE GOING TO BE ??

Stockpooper30 Posted - 5 days ago

$PAYS what your guys thoughts on this ??

Jpike55 Posted - 6 days ago

$PAYS Better than most stocks...look at the last 6 month chart.....getting stronger as she growths.

erevnon Posted - 6 days ago

Barrington Research maintains PaySign $PAYS at Outperform and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

Stockpooper30 Posted - 6 days ago

$PAYS this is not a profitable company at all

Stockpooper30 Posted - 6 days ago

$PAYS What do you guys think about earnings coming TOMORROW ??

thinkandpick Posted - 6 days ago

$PAYC $PAY $PAYO $PAYS $PAYX Paycom (PAYC): The Worst May Be Priced In, good SA article: https://seekingalpha.com/article/4683085-paycom-the-worst-may-be-priced-in

khmerxbxboi Posted - 1 week ago

$PAYS = the great I am. = you will see ;)

aramos8626 Posted - 1 week ago

$PAYS i like dis stock :)

mrleboef Posted - 1 week ago

$PAYS nice pickup below 5

vjtweet Posted - 1 week ago

$PAYS on long watch for a while.. not an easy buy as it is approaching 5.

Doozio Posted - 1 week ago

$pays ATENtion out of the tightness with huckleberries in 🧠⏰

khmerxbxboi Posted - 1 week ago

$SOFI + $PAYS = let's go !!!

erevnon Posted - 04/30/24

DA Davidson maintains PaySign $PAYS at Buy and raises the price target from $4.5 to https://marketsblock.com/stock-upgrades-and-downgrades/

11thestate Posted - 04/30/24

$PAYS Even if the deadline has passed you can still file for a late claim.

khmerxbxboi Posted - 04/29/24

$PAYS = $6 soon might see a run similar to ??? $MULN = LONGTERM AND WILL TRIGGER $LCID $GME = soon ...